Julie Jacquemyn

Julie Jacquemyn

Auto-generated profile, based on publicly available information

Julie Jacquemyn

Department of Physiology, University of Alberta, Edmonton, Canada

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 October 2017 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
JJJulie Jacquemyn
Julie Jacquemyn
ACAna Cascalho
Ana Cascalho
RGRose E Goodchild
Rose E Goodchild

26 August 2024 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
LGLindsey D. Goodman
Lindsey D. Goodman
IRIsha Ralhan
Isha Ralhan
XLXin Li
Xin Li
Shenzhao LuShenzhao Lu
Shenzhao Lu
MMMatthew J. Moulton
Matthew J. Moulton
HBHugo J. Bellen
Hugo J. Bellen

27 July 2021 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
JJJulie Jacquemyn
Julie Jacquemyn
JFJoyce Foroozandeh
Joyce Foroozandeh
KVKatlijn Vints
Katlijn Vints
JSJef Swerts
Jef Swerts
PVPatrik Verstreken
Patrik Verstreken
RGRose Goodchild
Rose Goodchild
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

4 February 2023 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
JJJulie Jacquemyn
Julie Jacquemyn
SKSabine Kuenen
Sabine Kuenen
JSJef Swerts
Jef Swerts
BPBenjamin Pavie
Benjamin Pavie
VVVinoy Vijayan
Vinoy Vijayan
PVPatrik Verstreken
Patrik Verstreken
Recent evidence links dysfunctional lipid metabolism to the pathogenesis of Parkinson’s disease, but the mechanisms are not resolved. Here, we generated a new Drosophila knock-in model of DNAJC6/Auxilin and find that the pathogenic mutation causes synaptic dysfunction, neurological defects and neurodegeneration, as well as specific lipid metabolism alterations. In these mutants, membrane lipids containing long-chain polyunsaturated fatty acids, including phosphatidylinositol lipid species that are key for synaptic vesicle recycling and organelle function, are reduced. Overexpression of another protein mutated in Parkinson’s disease, Synaptojanin-1, known to bind and metabolize specific phosphoinositides, rescues the DNAJC6/Auxilin lipid alterations, the neuronal function defects and neurodegeneration. Our work reveals a functional relation between two proteins mutated in Parkinsonism and implicates deregulated phosphoinositide metabolism in the maintenance of neuronal integrity and neuronal survival.

2 April 2026 in npj Parkinson's Disease
Verified
Journal Article
Open access
PDF file
JJJulie Jacquemyn
Julie Jacquemyn
SKSabine Kuenen
Sabine Kuenen
JSJef Swerts
Jef Swerts
BPBenjamin Pavie
Benjamin Pavie
VVVinoy Vijayan
Vinoy Vijayan
PVPatrik Verstreken
Patrik Verstreken

16 February 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JJJulie Jacquemyn
Julie Jacquemyn
BMBrian Mariott
Brian Mariott
JCJinlan Chang
Jinlan Chang
NLNathanael Y J Lee
Nathanael Y J Lee
LALuis F. Rubio Atonal
Luis F. Rubio Atonal
MIMaria S. Ioannou
Maria S. Ioannou
Intercellular transmission of α-synuclein contributes to Parkinson’s disease pathology. Yet, the mechanisms of α-synuclein spread are not fully understood. Here, we used live-cell microscopy to examine the impact of Parkinson’s disease associated lipid alterations on α-synuclein release. We discovered that increased glucosylceramides induce ectosome shedding from primary neurons, and from dopaminergic neurons derived from Parkinson’s disease patient iPSCs harboring mutations in GBA1 (N370S, L444P and W378G) and LRRK2 (G2019S and R1441H) compared to their isogenic control. We show that elevated glucosylceramide similarly increases vesicle release and uptake by other neurons in living mouse brains using 2-photon microscopy. Finally, we show that ectosomes are loaded with pathogenic α-synuclein and lead to the transmission of α-synuclein pathology to neighbouring neurons. These data reveal ectosomes as the predominant route for α-synuclein transmission that can only be appreciated by live-cell imaging technologies.